ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
eXIthera Announces IND for EP-7041 Trial for COVID-19 Thrombosis Prevention
March 08, 2021eXIthera Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial for EP-7041, a parenteral, potent, and selective small-molecule inhibitor ...
Pharma Sources Insight January 2025
